Towards Healthcare
AI in Genomics Market Size | 23.6% - CAGR by 2032

Artificial Intelligence (AI) in Genomics Market Size (USD 7,365.59 Mn) Report by 2032

The report covers AI in Genomics Market Segmentations such as offering into software and services, addressing drug discovery & development, precision medicine, diagnostics, animal research, agriculture and other applications. End users includes pharmaceutical & biotech companies, government organizations, research organizations and others. Technological examines machine learning, deep learning, supervised learning, reinforcement learning, unsupervised learning and other emerging technologies. Functionality evaluates genome sequencing, gene editing, clinical workflows and predictive genetic testing & preventive medicine. The report offers the value (in USD Million) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global AI in Genomics Market Assessment

  • Overview
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • Global AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Malaysia
      • Philippines
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of the Middle East & Africa

North America AI in Genomics Market Assessment

  • Overview
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • North America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.S.
    • Canada

Europe AI in Genomics Market Assessment

  • Overview
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • Europe AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.K.
    • Germany
    • France

Asia-Pacific AI in Genomics Market Assessment

  • Overview
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • Asia-Pacific AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines

Latin America AI in Genomics Market Assessment

  • Overview
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • Latin America AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • Brazil
    • Rest of Latin America

Middle East & Africa (MEA) AI in Genomics Market Assessment

  • Overview
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Offering (2021 – 2033)
    • Software
    • Services
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Drug Discovery & Development
    • Precision Medicine
    • Diagnostics
    • Animal Research and Agriculture
    • Others
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Pharmaceutical & Biotech Companies
    • Government Organizations
    • Research Organizations
    • Others
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other
    • Other Technologies
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Functionality (2021 – 2033)
    • Genome Sequencing
    • Gene Editing
    • Clinical Workflows
    • Predictive Genetic Testing & Preventive Medicine
  • Middle East & Africa (MEA) AI in Genomics Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Company Profiles

  • IBM
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • NVIDIA Corporation
  • Benevolent AI
  • Verge Genomics
  • MolecularMatch, Inc.
  • SOPHiA GENETICS
  • PrecisionLife Ltd.
  • Lifebit
  • FDNA, Inc.
  • Empiric Logic
  • Microsoft
  • Deep Genomics
  • Fabric Genomics Inc.
  • Freenome Holdings, Inc.
  • Cambridge Cancer Genomics
  • Data4Cure Inc.
  • Engine Biosciences Pte. Ltd
  • Genoox Ltd.
  • Diploid
  • DNAnexus Inc.

Conclusion & Recommendations

  • Insight Code: 5046
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: May 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Yes, AI can automate and streamline genomics workflows. AI technologies can automate steps involved in NGS workflows, such as sample preparation, sequencing, data analysis, and interpretation. This reduces manual labor, minimizes errors, and improves efficiency. AI-driven automation enables faster turnaround times, scalability, and cost-effectiveness in genomics research and clinical applications.

AI algorithms can help address data quality and standardization challenges in genomics by analyzing large datasets and identifying inconsistencies, errors, and biases. AI techniques can be applied to clean and preprocess genomic data, ensuring its quality and standardization. Additionally, AI can help identify patterns and develop algorithms that improve data standardization processes, enhancing the overall reliability and accuracy of genomic data analysis.

The future of AI in genomics is promising. As AI continues to advance and NGS technologies become more accessible, AI will play a critical role in driving genomics research, personalized medicine, and drug discovery. The integration of AI with other emerging technologies like single-cell genomics and spatial genomics holds great potential for further advancements in understanding human biology, and disease mechanisms and developing targeted therapies.

National Human Genome Research Institute, HHS’ Tracking Accountability in Government Grants System, and U.S. Department of Health & Human Services

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509